Chondrogenic differentiation of rat bone marrow mesenchymal stem cells induced by puerarin and tetrandrine

Abstract

Objective: This study aims to clarify the effect of the active components puerarin and tetrandrine on the chondrogenic differentiation of bone marrow mesenchymal stem cells (BMSCs).
Methods: Using network pharmacology, protein targets of puerarin and tetrandrine were predicted, and a database of cartilage formation targets was established. The protein target information related to disease was then collected, and the drug-targeting network was constructed by analyzing the protein-protein interactions. Genes related to chondrogenesis induced by puerarin and tetrandrine and chondroblast differentiation signaling pathways were searched. Finally, potential drug- and disease-related genes, as well as proteins, were screened and verified using real-time RT-PCR and western blotting.
Results: Network pharmacological studies have shown that puerarin and tetrandrine are involved in BMSCs cartilage differentiation. The experimental results showed that puerarin and tetrandrine could regulate the expression of cartilage differentiation-related genes and proteins. Puerarin increased the protein expression of COL2A1, COL10A1, MMP13, and SOX-9, as well as the gene expression of Col2a1, Mmp13, Tgfb1, and Sox-9. Tetrandrine increased the protein expression of COL2A1, COL10A1, MMP13, and SOX-9, as well as the gene expression of Col10a1, Tgfb1, Sox-9, and Acan. The combination of puerarin and tetrandrine increased the protein expression of COL2A1, COL10A1, MMP13, and SOX-9 and the gene expression of Col2a1, Col10a1, Sox-9, and Acan.
Conclusions: Puerarin, tetrandrine, and their combination can promote the proliferation of BMSCs and induce their differentiation into chondrocytes, and they are thus expected to be inducers of chondrogenic differentiation. These results suggest that puerarin and tetrandrine have potential therapeutic effects on osteoarthritis.

Keywords

Bone marrow mesenchymal stem cells (BMSCs) / Chondrogenic differentiation / Network pharmacology / Puerarin / Tetrandrine

References

[[1]] Hunter DJ, Bierma-Zeinstra S.Osteoarthritis. Lancet 2019;393(10182):1745-1759.

[[2]] Neogi T.The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage 2013;21(9):1145-1153.

[[3]] Johnson K, Zhu S, Tremblay MS, et al.A stem cell-based approach to cartilage repair. Science 2012;336(6082):717-721.

[[4]] Friedenstein AJ, Gorskaja JF, Kulagina NN.Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976;4(5):267-274.

[[5]] Tuan RS, Boland G, Tuli RJAR.Therapy. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 2003;5(1):32-45.

[[6]] Wang T, Tang W, Sun S, et al.Intravenous infusion of bone marrow mesenchymal stem cells improves myocardial function in a rat model of myocardial ischemia. Crit Care Med 2007;35(11):2587-2593.

[[7]] Spees JL, Lee RH, Gregory CA.Mechanisms of mesenchymal stem/ stromal cell function. Stem Cell Res Ther 2016;7(1):125.

[[8]] Huh Y, Ji RR, Chen G.Neuroinflammation, bone marrow stem cells, and chronic pain. Front Immunol 2017;8:1014.

[[9]] Johnstone B, Alini M, Cucchiarini M, et al.Tissue engineering for articular cartilage repair—the state of the art. Eur Cell Mater 2013;25:248-267.

[[10]] Qi Y, Feng G, Yan WQ.Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis. Mol Biol Rep May 2012;39(5):5683-5689.

[[11]] Murray SS, Murray EJB, Wang JC, et al.The history and histology of bone morphogenetic protein. Histol Histopathol 2016;31(7):11744.

[[12]] Bhang SH, Jeon JY, La WG, et al.Enhanced chondrogenic marker expression of human mesenchymal stem cells by interaction with both TGF-b3 and hyaluronic acid. Biotechnol Appl Biochem 2011;58(4):271-276.

[[13]] Madry H, Kaul G, Cucchiarini M, et al.Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther 2005;12(15):1171.

[[14]] Hopkins AL.Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 2008;4(11):682-690.

[[15]] Chen CY.TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico. PLoS One 2011;6(1):e15939.

[[16]] Wang Z, Linghu KG, Hu Y, et al.Deciphering the pharmacological mechanisms of the Huayu-Qiangshen-Tongbi formula through integrating network pharmacology and in vitro pharmacological investigation. Front Pharmacol 2019;10:1065.

[[17]] WuH, Zhao G, Jiang K, et al. Puerarin exerts an anti-inflammatory effect by inhibiting NF-kB and MAPK activation in Staphylococcus aureus-induced mastitis. Phytother Res 2016;30(10):1658-1664.

[[18]] Wei SY, Chen Y, Xu XY.Progress on the pharmacological research of puerarin: a review. Chin J Nat Med 2014;12(6):407-414.

[[19]] Cheng Y, Wang L, Tang M, et al.Effects of puerarin on cardiac differentiation and ventricular specialization of murine embryonic stem cells. Cell Physiol Biochem 2013;32(4):789-800.

[[20]] Cai H, Wu LL, Sun XC, et al.Effects of puerarin on proliferation and differentiation of umbilical cord mesenchymal stem cells into osteoblasts in vitro. Yao Xue Xue Bao 2011;46(6):738-741.

[[21]] Zhou Y, Lian H, Liu K, et al.Puerarin improves graft bone defect through microRNA-155-3p-mediated p53/TNF-a/STAT1 signaling pathway. Int J Mol Med 2020;46(1):239-251.

[[22]] Xu L, Zheng N, He Q, et al.Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-beta1/Smad signaling pathway, thereby leading to antifibrotic effect. Phytomedicine 2013;20(13):1172-1179.

[[23]] Renard E, Poree B, Chadjichristos C, et al.Sox9/Sox6 and Sp1 are involved in the insulin-like growth factor-I-mediated upregulation of human type II collagen gene expression in articular chondrocytes. J Mol Med (Berl) 2012;90(6):649-666.

[[24]] Li J, Zhao Z, Liu J, et al.MEK/ERK and p38 MAPK regulate chondrogenesis of rat bone marrow mesenchymal stem cells through delicate interaction with TGF-beta1/Smads pathway. Cell Prolif 2010;43(4):333-343.

[[25]] Wong R, Rabie B.Effect of puerarin on bone formation. Osteoarthritis Cartilage 2007;15(8):894-899.

[[26]] Wang X,WuJ, Chiba H, et al. Puerariae radix prevents bone loss in castrated male mice. Metabolism 2005;54(11):1536-1541.

[[27]] Choi HS, Kim HS, Min KR, et al.Anti-inflammatory effects of fangchinoline and tetrandrine. J Ethnopharmacol 2000;69(2):173-179.

[[28]] Cui YL, Yao KD, Qi AL, et al.Effect of tetrandrine on chondrocytes cultured in vitro. Chinese Traditional and Herbal Drugs 2006;37(12):1847-1850.

[[29]] Zhou X, Li W, Jiang L, et al.Tetrandrine inhibits the Wnt/betacatenin signalling pathway and alleviates osteoarthritis: an in vitro and in vivo study. Evid Based Complement Alternat Med 2013;2013:809579.

[[30]] Naito M, Ohashi A, Takahashi T.Dexamethasone inhibits chondrocyte differentiation by suppression of Wnt/b-catenin signaling in the chondrogenic cell line ATDC5. Histochem Cell Biol 2015;144(3):261-272.

[[31]] Song H, Park KH.Regulation and function of SOX9 during cartilage development and regeneration. Semin Cancer Biol 2020;67(Pt 1):12-23.

[[32]] Ichiro S, Vuoristo JT, Larson BL, et al.In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci U S A 2002;99(7):4397-4402.

[[33]] Zhao Q, Eberspaecher H, Lefebvre V, et al.Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 2010;209(4):377-386.

[[34]] Quintana L, zur Nieden NI, Semino CE. Morphogenetic and regulatory mechanisms during developmental chondrogenesis: new paradigms for cartilage tissue engineering. Tissue Eng Part B Rev 2009;15(1):29-41.

[[35]] Worster AA, Nixon AJ, Brower-Toland BD, et al.Effect of transforming growth factor beta1 on chondrogenic differentiation of cultured equine mesenchymal stem cells. Am J Vet Res 2000;61(9):1003-1010.

[[36]] Ohkubo K, Shimokawa H, Ogawa T, et al.Immunohistochemical localization of matrix metalloproteinase 13 (MMP-13) in mouse mandibular condylar cartilage. JMedDent Sci2003;50(3):203-211.

[[37]] Wang MK, Sun HQ, Xiang YC, et al.Different roles of TGF-beta in the multi-lineage differentiation of stem cells. World J Stem Cells 2012;4(5):28-34.

[[38]] Kondo S, Shukunami C, Morioka Y, et al.Dual effects of the membrane-anchored MMP regulator RECK on chondrogenic differentiation of ATDC5 cells. J Cell Sci 2007;120(Pt 5):849-857.

[[39]] Berendsen AD, Olsen BR.Bone development. Bone 2000;16(16):191-220.

[[40]] Delise AM, Fischer L, Tuan RS.Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage 2000;8(5):309-334.

[[41]] Goldring MB, Tsuchimochi K, Ijiri K.The control of chondrogenesis. J Cell Biochem 2010;97(1):33-44.

[[42]] Ichinose S, Tagami M, Muneta T, et al.Morphological examination during in vitro cartilage formation by human mesenchymal stem cells. Cell Tissue Res 2005;322(2):217.

[[43]] Sahar DE, Longaker MT, Quarto N.Sox9 neural crest determinant gene controls patterning and closure of the posterior frontal cranial suture. Dev Biol 2005;280(2):344-361.

[[44]] Shibata S, Fukada K, Imai H, et al.In situ hybridization and immunohistochemistry of versican, aggrecan and link protein, and histochemistry of hyaluronan in the developing mouse limb bud cartilage. J Anat 2010;203(4):425-432.